Literature DB >> 17575570

Mimicry of phase I drug metabolism--novel methods for metabolite characterization and synthesis.

Tove Johansson1, Lars Weidolf, Ulrik Jurva.   

Abstract

The extent to which electrochemical oxidation, electrochemically assisted Fenton chemistry and synthetic metalloporphines can be used to mimic cytochrome P450 catalyzed oxidations has been investigated for a large range of metabolic reactions. Most relevant metabolic oxidations can be mimicked by at least one of the three investigated systems. The EC oxidation system successfully mimics benzylic hydroxylation, hydroxylation of aromatic rings containing electron-donating groups, N-dealkylation, S-oxidation, dehydrogenation and less efficiently N-oxidation and O-dealkylation. The EC-Fenton system is able to mimic aliphatic hydroxylation, benzylic hydroxylation, aromatic hydroxylation, N-dealkylation, N-oxidation, O-dealkylation, S-oxidation and dehydrogenation. The porphine system mimics all types of reactions although the yields are low for some reactions. In conclusion, these three complementary systems can be used during the drug discovery and development of new drugs to elucidate the structure of metabolites that are difficult to characterize in biological matrices. Moreover, such techniques can replace the classical chemistry strategy, especially when synthesis is complicated or too time-consuming in order to access metabolites for further testing. Copyright 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17575570     DOI: 10.1002/rcm.3077

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  12 in total

1.  Electrochemistry-mass spectrometry unveils the formation of reactive triclocarban metabolites.

Authors:  A Baumann; W Lohmann; T Rose; K C Ahn; B D Hammock; U Karst; N H Schebb
Journal:  Drug Metab Dispos       Date:  2010-09-22       Impact factor: 3.922

2.  Preparative microfluidic electrosynthesis of drug metabolites.

Authors:  Romain Stalder; Gregory P Roth
Journal:  ACS Med Chem Lett       Date:  2013-10-01       Impact factor: 4.345

3.  In-line formation and identification of toxic reductive metabolites of aristolochic acid using electrochemistry mass spectrometry coupling.

Authors:  Ugo Bussy; Renaud Boisseau; Mikaël Croyal; Ranil C T Temgoua; Mohammed Boujtita
Journal:  Anal Bioanal Chem       Date:  2022-01-13       Impact factor: 4.142

4.  Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.

Authors:  Jong Yeon Hwang; Leggy A Arnold; Fangyi Zhu; Aaron Kosinski; Thomas J Mangano; Vincent Setola; Bryan L Roth; R Kiplin Guy
Journal:  J Med Chem       Date:  2009-07-09       Impact factor: 7.446

Review 5.  Mass spectrometric methods for monitoring redox processes in electrochemical cells.

Authors:  Herbert Oberacher; Florian Pitterl; Robert Erb; Sabine Plattner
Journal:  Mass Spectrom Rev       Date:  2013-12-10       Impact factor: 10.946

6.  Charged Tags for the Identification of Oxidative Drug Metabolites Based on Electrochemistry and Mass Spectrometry.

Authors:  Alexandra Gutmann; Lars Julian Wesenberg; Nadine Peez; Siegfried R Waldvogel; Thorsten Hoffmann
Journal:  ChemistryOpen       Date:  2020-05-06       Impact factor: 2.911

7.  Antioxidant Properties and Oxidative Transformation of Different Chromone Derivatives.

Authors:  Evelin Csepanyi; Peter Szabados-Furjesi; Attila Kiss-Szikszai; Lisa M Frensemeier; Uwe Karst; Istvan Lekli; David D Haines; Arpad Tosaki; Istvan Bak
Journal:  Molecules       Date:  2017-04-06       Impact factor: 4.411

8.  Synthesis, in Vitro Biological Evaluation, and Oxidative Transformation of New Flavonol Derivatives: The Possible Role of the Phenyl-N,N-Dimethylamino Group.

Authors:  Peter Szabados-Furjesi; David Pajtas; Aliz Barta; Evelin Csepanyi; Attila Kiss-Szikszai; Arpad Tosaki; Istvan Bak
Journal:  Molecules       Date:  2018-11-30       Impact factor: 4.411

9.  Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe Drug.

Authors:  Benjamin Berger; Fabio Bachmann; Urs Duthaler; Stephan Krähenbühl; Manuel Haschke
Journal:  Front Pharmacol       Date:  2018-07-24       Impact factor: 5.810

10.  Mimicking of Phase I Metabolism Reactions of Molindone by HLM and Photocatalytic Methods with the Use of UHPLC-MS/MS.

Authors:  Maciej Gawlik; Vladimir Savic; Milos Jovanovic; Robert Skibiński
Journal:  Molecules       Date:  2020-03-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.